We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$369B
AUM Growth
-$12.6B
(-3.3%)
Cap. Flow
+$3.24B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
31.8%
Holding
3,300
New
48
Increased
1,756
Reduced
1,134
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.25B |
| 2 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$938M |
| 3 |
Apple
AAPL
|
+$911M |
| 4 |
Costco
COST
|
+$878M |
| 5 |
NVIDIA
NVDA
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.69B |
| 2 |
ServiceNow
NOW
|
+$651M |
| 3 |
Applied Materials
AMAT
|
+$563M |
| 4 |
Visa
V
|
+$536M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$523M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Financials | 11.41% |
| 3 | Consumer Discretionary | 10.18% |
| 4 | Industrials | 9.65% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Home BancShares
HOMB
$6.09B
| $67.6M | 0.02% |
2,511,892
-264,577
| -10% | -$7.45M |
|
527
Black Hills Corp
BKH
$5.71B
| $67.6M | 0.02% |
973,246
-256,959
| -21% | -$18.5M |
|
528
International Flavors & Fragrances
IFF
$18.5B
| $66.9M | 0.02% |
921,883
+116,562
| +14% | +$8.56M |
|
|
BCPC
529
Balchem Corp
BCPC
$5.18B
| $66.7M | 0.02% |
393,485
-2,737
| -0.7% | -$465K |
|
530
Five Below
FIVE
$11.3B
| $66.6M | 0.02% |
291,605
+91,553
| +46% | +$19.2M |
|
531
Westlake Corp
WLK
$9.77B
| $66M | 0.02% |
564,744
-88,165
| -14% | -$8.55M |
|
532
Biogen
BIIB
$29.8B
| $65.8M | 0.02% |
358,838
-16,719
| -4% | -$3.08M |
|
533
PBF Energy
PBF
$7.43B
| $65.8M | 0.02% |
1,381,031
+314,507
| +29% | +$11.8M |
|
534
Huntington Bancshares
HBAN
$35.3B
| $65.5M | 0.02% |
4,188,062
+1,020,268
| +32% | +$17.4M |
|
535
Jazz Pharmaceuticals
JAZZ
$15.9B
| $65.4M | 0.02% |
346,148
-35,789
| -9% | -$6.25M |
|
536
Labcorp
LH
$23.5B
| $65.3M | 0.02% |
244,836
+39,248
| +19% | +$10.6M |
|
|
CHYM
537
Chime Financial
CHYM
$7.93B
| $65.1M | 0.02% |
3,475,351
+745,586
| +27% | +$16.9M |
|
538
BrightSpring Health Services
BTSG
$13.5B
| $65M | 0.02% |
1,525,169
-116,977
| -7% | -$4.71M |
|
539
Cognizant
CTSH
$20.2B
| $64.5M | 0.02% |
1,050,540
+21,020
| +2% | +$1.5M |
|
540
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $64.3M | 0.02% |
1,189,959
+196,085
| +20% | +$11M |
|
541
Federal Signal
FSS
$7.22B
| $64.2M | 0.02% |
593,225
-4,173
| -0.7% | -$472K |
|
542
Coca-Cola Europacific Partners
CCEP
$45.7B
| $64M | 0.02% |
706,211
-493,745
| -41% | -$47.4M |
|
543
FTAI Aviation
FTAI
$22.4B
| $63.3M | 0.02% |
258,479
+34,533
| +15% | +$9.14M |
|
|
NVMI
544
Nova
NVMI
$14.4B
| $63.3M | 0.02% |
147,255
-1,294
| -0.9% | -$570K |
|
545
DTE Energy
DTE
$30.9B
| $63.1M | 0.02% |
431,600
-10,207
| -2% | -$1.44M |
|
546
Wheaton Precious Metals
WPM
$49.9B
| $63.1M | 0.02% |
482,141
+1,957
| +0.4% | +$272K |
|
|
ECHO
547
EchoStar
ECHO
$26.2B
| $63.1M | 0.02% |
538,845
+82,930
| +18% | +$9.52M |
|
548
Dollar General
DG
$25.3B
| $63M | 0.02% |
530,836
+7,859
| +2% | +$1.12M |
|
|
NUMI
549
Nuveen Municipal Income ETF
NUMI
$81.7M
| $63M | 0.02% |
2,525,000
-25,000
| -1% | -$631K |
|
550
Insulet
PODD
$11B
| $62.7M | 0.02% |
298,791
+64,306
| +27% | +$16.2M |
|
Similar funds
VFT
Nuveen's Q1 2026 Portfolio in Review
As of Q1 2026, Nuveen held 3,300 positions worth $369B, down 3.3% from $382B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.8%. Nuveen opened 48 new positions and exited 76, leaving the 3,300-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,483,995 shares worth $156M.
- Nuveen added most to AstraZeneca in Q1 2026, an estimated $1.25B increase.
- Nuveen's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.69B.
- Nuveen fully exited Exact Sciences in Q1 2026, selling an estimated $82.6M.
- Nuveen's ten largest holdings make up 32% of its $369B portfolio in Q1 2026.
- Nuveen opened 48 new positions and closed 76 in Q1 2026.
- Nuveen's portfolio value fell 3.3% quarter-over-quarter to $369B.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.